Generative AI, while revolutionary, poses significant risks if misused, particularly in the creation of bioweapons. Executives from prominent AI firms, including Sam Altman (OpenAI), Mustafa Suleyman (Microsoft AI), Demis Hassabis (Google DeepMind), and Dario Amodei (Anthropic), have raised alarms about these threats. They have signed a public letter urging the US Congress to enact laws that would enforce stricter screening processes for companies selling RNA and DNA to prevent misuse. The letter also includes support from gene synthesis firms, national security experts, and scientists. The evolution of gene synthesis technology has made it easier to produce custom genetic sequences, which are now widely available. However, the concern is that AI can help individuals bypass existing screening measures, making it crucial to establish regulatory guardrails to mitigate these risks. The executives emphasize that AI cannot be fully trusted in sensitive applications, and proactive measures are necessary to avert potential dangers.